Your browser doesn't support javascript.
loading
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.
Muscarella, Peter; Bekaii-Saab, Tanios; McIntyre, Kristi; Rosemurgy, Alexander; Ross, Sharona B; Richards, Donald A; Fisher, William E; Flynn, Patrick J; Mattson, Alicia; Coeshott, Claire; Roder, Heinrich; Roder, Joanna; Harrell, Frank E; Cohn, Allen; Rodell, Timothy C; Apelian, David.
Afiliação
  • Muscarella P; Department of Surgery, Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
  • Bekaii-Saab T; Mayo Clinic Cancer Center, Phoenix, Arizona, USA.
  • McIntyre K; Texas Oncology, US Oncology Research, Dallas, Texas, USA.
  • Rosemurgy A; Digestive Disorders Institute, AdventHealth Tampa, Tampa, Florida, USA.
  • Ross SB; Digestive Disorders Institute, AdventHealth Tampa, Tampa, Florida, USA.
  • Richards DA; Texas Oncology, US Oncology Research, Tyler, Texas, USA.
  • Fisher WE; Baylor College of Medicine, Houston, Texas, USA.
  • Flynn PJ; Minnesota Oncology, US Oncology Research, Minneapolis, Minnesota, USA.
  • Mattson A; Smuggler Mountain Group (SMG, Inc.), Aspen, Colorado, USA.
  • Coeshott C; Smuggler Mountain Group (SMG, Inc.), Aspen, Colorado, USA.
  • Roder H; Biodesix, Inc., Boulder, Colorado, USA.
  • Roder J; Biodesix, Inc., Boulder, Colorado, USA.
  • Harrell FE; Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • Cohn A; Rocky Mountain Cancer Center, Denver, Colorado, USA.
  • Rodell TC; Smuggler Mountain Group (SMG, Inc.), Aspen, Colorado, USA.
  • Apelian D; Smuggler Mountain Group (SMG, Inc.), Aspen, Colorado, USA.
J Pancreat Cancer ; 7(1): 8-19, 2021.
Article em En | MEDLINE | ID: mdl-33786412

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article